• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

Concizumab Antibody – Monoclonal

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5819197

Concizumab is an anti-TFPI monoclonal antibody (IgG4 type) that selectively binds to the Kunitz protease Inhibitor (KPI) 2 domain of TFPI, thereby blocking the interaction of this domain with the FXa active site. Injections of Concizumab increase thrombin in… More details

Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
Concizumab, Monoclonal Antibody
Full Product Name
Concizumab
Product Synonym Names
mAb 2021; NN 7415
Clonality
Monoclonal
Preparation and Storage
Powder: -20 degree C for 3 years | In solvent: -80 degree C for 1 year
Solubility
(< 1 mg/ml refers to the product slightly soluble or insoluble)
CAS Number
1312299-39-0
In_vitro
In cynomolgus monkeys, Concizumab (i.v./s.c.) blocked the interaction between TFPI and FXa active site [2].

Other Notes

Small volumes of anti-Concizumab antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for Concizumab purchase

MBS5819197 is an antibody targeting Concizumab.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000